Actionnariat et activité des initiés pour Prelude Therapeutics Incorporated (PRLD): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.47 |
| Capitalisation | $254M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-09 | BAKER BROS. ADVISORS LP | A-Award | 38,000 | $150K |
| 2026-06-09 | Dorton Katina | A-Award | 38,000 | $150K |
| 2026-06-09 | Babler Martin | A-Award | 38,000 | $150K |
| 2026-06-09 | Bonita David P | A-Award | 38,000 | $150K |
| 2026-06-09 | Sandor Victor | A-Award | 38,000 | $150K |
| 2026-06-09 | FRIEDMAN PAUL A | A-Award | 38,000 | $150K |
| 2026-05-01 | Morris Charles Q | A-Award | 450,000 | $2.1M |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | J-Other | 1,407,000 | $141 |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | J-Other | 1,407,000 | $141 |
| 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $15.6M | $18.9M | $218.3M | $31.8M | $30.6M | $25.3M | $12.5M | $35.3M |
| Placements à Court Terme | 0 | 0 | 0 | $259.4M | $171.1M | $207.6M | $121.1M | $68.0M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $15.6M | $20.2M | $220.8M | $295.1M | $204.4M | $235.6M | $135.9M | $105.7M |
| Immobilisations Corporelles | $811000 | $1.6M | $2.5M | $5.6M | $6.7M | $37.7M | $35.5M | $32.3M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $16.4M | $21.9M | $223.6M | $305.1M | $220.5M | $277.7M | $175.5M | $141.3M |
| Dettes Fournisseurs | $1.4M | $2.0M | $3.9M | $7.8M | $6.8M | $4.6M | $7.7M | $4.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.4M | $4.8M | $11.4M | $19.2M | $21.7M | $21.8M | $25.6M | $53.0M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $39.1M | $71.3M | $11.4M | $19.2M | $25.1M | $40.6M | $44.1M | $72.7M |
| Réserves | -$22.9M | -$50.5M | -$107.4M | -$219.1M | -$334.6M | -$456.4M | -$583.6M | -$683.1M |
| Capitaux Propres | -$22.7M | -$49.4M | $212.2M | $285.9M | $195.4M | $237.1M | $131.5M | $68.6M |
| Dette Totale | 0 | $258000 | 0 | $1.7M | $1.8M | $16.9M | $18.0M | $17.8M |
| Dette Nette | -$15.6M | -$18.6M | -$218.3M | -$289.5M | -$199.9M | -$216.0M | -$115.6M | -$85.4M |
| Fonds de Roulement | $13.1M | $15.4M | $209.4M | $275.9M | $182.7M | $213.8M | $110.3M | $52.7M |
Santé financière
| Dette / Capitaux propres | 0.13 |
| Ratio de liquidité | 4.07 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -7.34 |
Rentabilité
| Rentabilité des capitaux propres | -75.35% |
| Rentabilité du capital investi | -43.74% |
| Rentabilité des actifs | -31.94% |
| Marge brute | 98.26% |
| Marge opérationnelle | -300.56% |
| Marge nette | -269.75% |
Entreprises liées: AVTX · CRBU · ENTA · EPRX · FHTX · IMRX · IVA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de PRLD: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions